MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - mnc pharma
- GSK PHARMA - ADCOCK INGRAM (S. Africa)
GSK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results
GSK PHARMA Change
GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More
ADCOCK INGRAM (S. Africa)
Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
Financials
 GSK PHARMA  ADCOCK INGRAM |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| GSK PHARMA Mar-19 |
ADCOCK INGRAM Jun-14 |
GSK PHARMA/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 3,595 | 354 | - | |
| Low | Rs | 1,253 | 255 | - | |
| Sales per share (Unadj.) | Rs | 184.7 | 105.2 | - | |
| Earnings per share (Unadj.) | Rs | 26.3 | -26.5 | - | |
| Cash flow per share (Unadj.) | Rs | 29.2 | -22.0 | - | |
| Dividends per share (Unadj.) | Rs | 20.00 | 0 | - | |
| Dividend yield (eoy) | % | 0.8 | 0 | - | |
| Book value per share (Unadj.) | Rs | 126.3 | 82.6 | - | |
| Shares outstanding (eoy) | m | 169.40 | 168.78 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 13.1 | 2.9 | 453.7% | |
| Avg P/E ratio | x | 92.2 | -11.5 | -802.9% | |
| P/CF ratio (eoy) | x | 83.1 | -13.9 | -599.9% | |
| Price / Book Value ratio | x | 19.2 | 3.7 | 520.6% | |
| Dividend payout | % | 76.1 | 0 | - | |
| Avg Mkt Cap | Rs m | 410,626 | 51,396 | 799.0% | |
| No. of employees | `000 | 5.0 | 4.3 | 115.5% | |
| Total wages/salary | Rs m | 5,372 | 3,226 | 166.5% | |
| Avg. sales/employee | Rs Th | 6,306.7 | 4,137.7 | 152.4% | |
| Avg. wages/employee | Rs Th | 1,083.1 | 751.4 | 144.1% | |
| Avg. net profit/employee | Rs Th | 898.0 | -1,042.6 | -86.1% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 31,281 | 17,763 | 176.1% | |
| Other income | Rs m | 1,023 | 124 | 822.5% | |
| Total revenues | Rs m | 32,304 | 17,888 | 180.6% | |
| Gross profit | Rs m | 6,009 | -3,078 | -195.2% | |
| Depreciation | Rs m | 486 | 767 | 63.4% | |
| Interest | Rs m | 6 | 481 | 1.2% | |
| Profit before tax | Rs m | 6,540 | -4,202 | -155.7% | |
| Minority Interest | Rs m | 0 | -12 | 0.0% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 287 | 0 | - | |
| Tax | Rs m | 2,373 | 263 | 903.8% | |
| Profit after tax | Rs m | 4,454 | -4,476 | -99.5% | |
| Gross profit margin | % | 19.2 | -17.3 | -110.8% | |
| Effective tax rate | % | 36.3 | -6.2 | -580.7% | |
| Net profit margin | % | 14.2 | -25.2 | -56.5% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 20,061 | 13,010 | 154.2% | |
| Current liabilities | Rs m | 14,543 | 7,320 | 198.7% | |
| Net working cap to sales | % | 17.6 | 32.0 | 55.1% | |
| Current ratio | x | 1.4 | 1.8 | 77.6% | |
| Inventory Days | Days | 57 | 111 | 51.2% | |
| Debtors Days | Days | 14 | 124 | 11.3% | |
| Net fixed assets | Rs m | 14,343 | 7,584 | 189.1% | |
| Share capital | Rs m | 1,694 | 82 | 2,054.0% | |
| Net worth | Rs m | 21,398 | 13,942 | 153.5% | |
| Long term debt | Rs m | 2 | 4,900 | 0.0% | |
| Total assets | Rs m | 39,113 | 26,338 | 148.5% | |
| Interest coverage | x | 1,091.0 | -7.7 | -14,109.7% | |
| Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
| Sales to assets ratio | x | 0.8 | 0.7 | 118.6% | |
| Return on assets | % | 11.4 | -15.2 | -75.2% | |
| Return on equity | % | 20.8 | -32.1 | -64.8% | |
| Return on capital | % | 31.9 | -19.8 | -161.2% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 3,994 | 1,516 | 263.4% | |
| From Investments | Rs m | -1,433 | -466 | 307.9% | |
| From Financial Activity | Rs m | -3,584 | 4,447 | -80.6% | |
| Net Cashflow | Rs m | -1,023 | 5,497 | -18.6% | |
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.88 Rs / ZAR
Compare GSK PHARMA With: ACTAVIS (US) MYLAN (US) TEVA PHARMA (Israel)
Compare GSK PHARMA With: VENUS REMEDIES STRIDES PHARMA SCIENCE LUPIN SUN PHARMA DR. DATSONS LABS
Today's Market
4 Reasons Why Sensex Surged 750 Points Today(Closing)
Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.
Related Views On News
GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)
Feb 10, 2021 | Updated on Feb 10, 2021For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.
GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)
Oct 30, 2020 | Updated on Oct 30, 2020For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.
GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)
Jun 24, 2019 | Updated on Jun 24, 2019Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.
More Views on NewsMost Popular
It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)
Feb 24, 2021Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)
Feb 16, 2021A look at what India's top equity mutual funds bought and sold in January 2021.
I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)
Feb 16, 2021Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)
Feb 25, 2021In this video, I'll show you how to get started on the path to daily trading profits.
More
